103 related articles for article (PubMed ID: 30979916)
1. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
[TBL] [Abstract][Full Text] [Related]
2. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
Brumme Z; Wang B; Nair K; Brumme C; de Pierres C; Reddy S; Julg B; Moodley E; Thobakgale C; Lu Z; van der Stok M; Bishop K; Mncube Z; Chonco F; Yuki Y; Frahm N; Brander C; Carrington M; Freedberg K; Kiepiela P; Goulder P; Walker B; Ndung'u T; Losina E
Clin Infect Dis; 2009 Sep; 49(6):956-64. PubMed ID: 19663693
[TBL] [Abstract][Full Text] [Related]
3. Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy.
Love M; Behrens-Bradley N; Ahmad A; Wertheimer A; Klotz S; Ahmad N
Viral Immunol; 2024 May; 37(4):202-215. PubMed ID: 38717822
[TBL] [Abstract][Full Text] [Related]
4. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.
Parikh RV; Scherzer R; Grunfeld C; Nitta EM; Leone A; Martin JN; Deeks SG; Ganz P; Hsue PY
Atherosclerosis; 2013 Jul; 229(1):246-52. PubMed ID: 23711612
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection.
El Hed A; Khaitan A; Kozhaya L; Manel N; Daskalakis D; Borkowsky W; Valentine F; Littman DR; Unutmaz D
J Infect Dis; 2010 Mar; 201(6):843-54. PubMed ID: 20144043
[TBL] [Abstract][Full Text] [Related]
7. Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts.
Sipsas NV; Sfikakis PP; Kontos A; Kordossis T
Clin Diagn Lab Immunol; 2002 May; 9(3):558-61. PubMed ID: 11986259
[TBL] [Abstract][Full Text] [Related]
8. The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.
Gijsbers EF; van Sighem A; Harskamp AM; Welkers MR; de Wolf F; Brinkman K; Prins JM; Schuitemaker H; van 't Wout AB; Kootstra NA
PLoS One; 2013; 8(10):e76255. PubMed ID: 24098454
[TBL] [Abstract][Full Text] [Related]
9. Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection.
Swaminathan S; Hu Z; Rupert AW; Higgins JM; Dewar RL; Stevens R; Chen Q; Rehm CA; Metcalf JA; Baseler MW; Lane HC; Imamichi T
PLoS One; 2014; 9(6):e98989. PubMed ID: 24896094
[TBL] [Abstract][Full Text] [Related]
10. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
[TBL] [Abstract][Full Text] [Related]
11. High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load.
Santos-Oliveira JR; Giacoia-Gripp CB; Alexandrino de Oliveira P; Amato VS; Lindoso JÂ; Goto H; Oliveira-Neto MP; Mattos MS; Grinsztejn B; Morgado MG; Da-Cruz AM
BMC Infect Dis; 2010 Dec; 10():358. PubMed ID: 21171992
[TBL] [Abstract][Full Text] [Related]
12. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
13. TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Oriol-Tordera B; Olvera A; Duran-Castells C; Llano A; Mothe B; Massanella M; Dalmau J; Ganoza C; Sanchez J; Calle ML; Clotet B; Martinez-Picado J; Negredo E; Blanco J; Hartigan-O'Connor D; Brander C; Ruiz-Riol M
J Immunol; 2020 Dec; 205(12):3348-3357. PubMed ID: 33177161
[TBL] [Abstract][Full Text] [Related]
14. HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.
Barbour JD; Sauer MM; Sharp ER; Garrison KE; Long BR; Tomiyama H; Bassichetto KC; Oliveira SM; Abbate MC; Nixon DF; Kallas EG
PLoS One; 2007 Oct; 2(10):e1080. PubMed ID: 17957262
[TBL] [Abstract][Full Text] [Related]
15. Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.
Miller EA; Spadaccia MR; OʼBrien MP; Rolnitzky L; Sabado R; Manches O; Frleta D; Bhardwaj N
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):535-44. PubMed ID: 22902724
[TBL] [Abstract][Full Text] [Related]
16. Better Viral Control despite Higher CD4
El-Badry E; Macharia G; Claiborne D; Brooks K; Dilernia DA; Goepfert P; Kilembe W; Allen S; Gilmour J; Hunter E
J Virol; 2020 Jul; 94(16):. PubMed ID: 32461316
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.
Raugi DN; Gottlieb GS; Sow PS; Toure M; Sall F; Gaye A; N'doye I; Kiviat NB; Hawes SE;
AIDS; 2013 Sep; 27(15):2441-50. PubMed ID: 23665777
[TBL] [Abstract][Full Text] [Related]
18. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.
Gosselin A; Wiche Salinas TR; Planas D; Wacleche VS; Zhang Y; Fromentin R; Chomont N; Cohen ÉA; Shacklett B; Mehraj V; Ghali MP; Routy JP; Ancuta P
AIDS; 2017 Jan; 31(1):35-48. PubMed ID: 27835617
[TBL] [Abstract][Full Text] [Related]
19. Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism.
Ni W; Ren L; Liao L; Li D; Luo Z; Zhu M; Liu Y; Xing H; Wang Z; Shao Y
Front Immunol; 2024; 15():1378048. PubMed ID: 38799426
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy.
Cattin A; Wiche Salinas TR; Gosselin A; Planas D; Shacklett B; Cohen EA; Ghali MP; Routy JP; Ancuta P
AIDS; 2019 Jul; 33(8):1293-1306. PubMed ID: 30870200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
